• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一些新型喹喔啉二酮二芳酰胺索拉非尼类似物的合成与细胞毒性评价

Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues.

作者信息

Khandan Mojtaba, Sadeghian-Rizi Sedighe, Khodarahmi Ghadamali, Hassanzadeh Farshid

机构信息

Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.

出版信息

Res Pharm Sci. 2018 Apr;13(2):168-176. doi: 10.4103/1735-5362.223802.

DOI:10.4103/1735-5362.223802
PMID:29606971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5842488/
Abstract

A series of novel sorafenib analogues containing a quinoxalinedione ring and amide linker were synthesized. A total of 9 novel compounds in 6 synthetic steps were synthesized. Briefly, the amino group of p-aminophenol was first protected which then followed by O-arylation with 5-chloro-2-nitroaniline to provide compound . Reduction of the nitro group of compound and cyclization of the diamine group of compound with oxalic acid afforded compound which on deacetylation yeilded compound . Then compound was reacted with different acyl halides to afford the target compounds . Chemical structures of synthesized compounds were confirmed by 1H NMR and FT-IR analysis. All compounds were evaluated at 1, 10, 50 and 100 μM concentrations for their cytotoxicity against HeLa and MCF-7 cancer cell lines. Some of the compounds showed good cytotoxic activity, especially compounds and with the IC50 values of 19, 16, 22, 18, and 16 μM against MCF-7 cell line and 20, 18, 25, 20, and 18 μM against HeLa cell line, respectively.

摘要

合成了一系列含有喹喔啉二酮环和酰胺连接基的新型索拉非尼类似物。通过6步合成总共得到了9种新型化合物。简要来说,对氨基苯酚的氨基首先被保护,然后与5-氯-2-硝基苯胺进行O-芳基化反应得到化合物 。化合物 的硝基还原以及化合物 的二胺基团与草酸环化得到化合物 ,化合物 脱乙酰基得到化合物 。然后化合物 与不同的酰卤反应得到目标化合物 。通过1H NMR和FT-IR分析确认了合成化合物的化学结构。对所有化合物在1、10、50和100 μM浓度下针对HeLa和MCF-7癌细胞系的细胞毒性进行了评估。一些化合物表现出良好的细胞毒性活性,尤其是化合物 和 ,它们对MCF-7细胞系的IC50值分别为19、16、22、18和16 μM,对HeLa细胞系的IC50值分别为20、18、25、20和18 μM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/250e204fb5d1/RPS-13-168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/927aa793a471/RPS-13-168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/2bf4a3262895/RPS-13-168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/250e204fb5d1/RPS-13-168-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/927aa793a471/RPS-13-168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/2bf4a3262895/RPS-13-168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5527/5842488/250e204fb5d1/RPS-13-168-g005.jpg

相似文献

1
Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues.一些新型喹喔啉二酮二芳酰胺索拉非尼类似物的合成与细胞毒性评价
Res Pharm Sci. 2018 Apr;13(2):168-176. doi: 10.4103/1735-5362.223802.
2
Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.一些含喹喔啉二酮部分的新型二芳基脲衍生物的合成与表征
Res Pharm Sci. 2018 Feb;13(1):82-92. doi: 10.4103/1735-5362.220971.
3
Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3.3位带有取代苯并咪唑的新型喹喔啉酮衍生物的合成及细胞毒性评价
Res Pharm Sci. 2019 Jun;14(3):247-254. doi: 10.4103/1735-5362.258493.
4
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.新型2-呋喃苯并咪唑类VEGFR-2抑制剂的设计、合成、分子对接及细胞毒性评价
Eur J Med Chem. 2017 Aug 18;136:315-329. doi: 10.1016/j.ejmech.2017.04.068. Epub 2017 Apr 26.
5
Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit.含磺酰脲单元的索拉非尼类似物的设计、合成、活性及对接研究
Molecules. 2015 Oct 23;20(10):19361-71. doi: 10.3390/molecules201019361.
6
Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line.齐墩果酸类似物的合成及其对3T3细胞系的细胞毒性作用。
Med Chem. 2018;14(6):617-625. doi: 10.2174/1573406414666180222094544.
7
Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.含查尔酮单元的新型索拉非尼类似物的设计、合成与活性
Bioorg Med Chem Lett. 2016 Nov 15;26(22):5450-5454. doi: 10.1016/j.bmcl.2016.10.029. Epub 2016 Oct 12.
8
Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides.索拉非尼衍生物N-(3-氟-4-(吡啶-4-基氧基)苯基)-4(5)-苯基吡啶甲酰胺的合成、生物学评价及对接研究
Med Chem. 2017;13(2):176-185. doi: 10.2174/1573406413666161117123203.
9
Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.新型AMPA受体拮抗剂:1-羟基-7-(1H-咪唑-1-基)-6-硝基-2,3(1H,4H)-喹喔啉二酮及相关化合物的合成与构效关系
J Med Chem. 1996 Sep 27;39(20):3971-9. doi: 10.1021/jm960387+.
10
Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.含脲基新型吡咯并[2,3-d]嘧啶衍生物对癌细胞系的细胞毒性和凋亡作用
Anticancer Agents Med Chem. 2018;18(9):1303-1312. doi: 10.2174/1871520618666180605082026.

引用本文的文献

1
Role of heterocycles in inhibition of VEGFR-2 - a recent update (2019-2022).杂环化合物在抑制血管内皮生长因子受体-2中的作用——最新进展(2019 - 2022年)
RSC Med Chem. 2023 Dec 12;15(2):416-432. doi: 10.1039/d3md00506b. eCollection 2024 Feb 21.
2
Novel VEGFR2 inhibitors with thiazoloquinoxaline scaffold targeting hepatocellular carcinoma with lower cardiotoxic impact.以噻唑并喹喔啉骨架为靶点的新型 VEGFR2 抑制剂,具有较低的心脏毒性作用,可用于治疗肝细胞癌。
Sci Rep. 2023 Aug 25;13(1):13907. doi: 10.1038/s41598-023-40832-z.
3
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.

本文引用的文献

1
Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.一些含喹喔啉二酮部分的新型二芳基脲衍生物的合成与表征
Res Pharm Sci. 2018 Feb;13(1):82-92. doi: 10.4103/1735-5362.220971.
2
Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.新型 RAF 激酶抑制性抗增殖喹啉衍生物的设计与合成。第 2 部分:二芳基脲衍生物。
Eur J Med Chem. 2017 Feb 15;127:413-423. doi: 10.1016/j.ejmech.2017.01.006. Epub 2017 Jan 5.
3
Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.
新型 3-甲基喹喔啉衍生物作为 VEGFR-2 抑制剂和凋亡诱导剂的设计、合成、对接、ADMET 研究和抗癌评估。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1760-1782. doi: 10.1080/14756366.2021.1956488.
含查尔酮单元的新型索拉非尼类似物的设计、合成与活性
Bioorg Med Chem Lett. 2016 Nov 15;26(22):5450-5454. doi: 10.1016/j.bmcl.2016.10.029. Epub 2016 Oct 12.
4
BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2.BRAF激酶抑制剂通过抑制FGFR2对乳腺癌细胞发挥抗肿瘤活性。
Am J Cancer Res. 2016 May 1;6(5):1040-52. eCollection 2016.
5
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.基于呋嘧啶和噻吩并嘧啶骨架的强效血管内皮生长因子受体-2(VEGFR-2)抑制剂作为癌症靶向药物的发现。
Sci Rep. 2016 Apr 15;6:24460. doi: 10.1038/srep24460.
6
A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy.索拉非尼和SC-43联合使用是一种具有协同作用的SHP-1激动剂组合,可推动肝细胞癌治疗的进展。
Cancer Lett. 2016 Feb 28;371(2):205-13. doi: 10.1016/j.canlet.2015.11.039. Epub 2015 Dec 8.
7
Cytotoxicity and antiangiogenic effects of Rhus coriaria, Pistacia vera and Pistacia khinjuk oleoresin methanol extracts.盐肤木、阿月浑子和笃耨香树脂甲醇提取物的细胞毒性和抗血管生成作用。
Res Pharm Sci. 2015 May-Jun;10(3):233-40.
8
Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit.含磺酰脲单元的索拉非尼类似物的设计、合成、活性及对接研究
Molecules. 2015 Oct 23;20(10):19361-71. doi: 10.3390/molecules201019361.
9
Probing a 3,4'-bis-guanidinium diaryl derivative as an allosteric inhibitor of the Ras pathway.探索一种3,4'-双胍基二芳基衍生物作为Ras途径的变构抑制剂。
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4287-92. doi: 10.1016/j.bmcl.2015.07.082. Epub 2015 Aug 18.
10
Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives.含1,3,4-恶二唑衍生物的二芳基酰胺和二芳基脲的合成及其广谱抗增殖活性
Bioorg Med Chem Lett. 2015 Apr 15;25(8):1692-1699. doi: 10.1016/j.bmcl.2015.03.001. Epub 2015 Mar 7.